The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
Open accessAbstract
Background & aims Moderate cure rates of acute hepatitis C virus (HCV) infections with pegylated interferon and ribavirin have been described in the last decade in men who have sex with men (MSM), who are also coinfected with the human immunodeficiency virus (HIV). However, a subsequent high incidence of HCV reinfections has been reported regionally in men who both clear the infection spontaneously or who respond to treatment.Methods Retrospective analysis of reinfections in HIV infected MSM in eight centers from Austria, France, Germany, and the UK within the NEAT network between May 2002 and June 2014.Results Of 606 individuals who cleared HCV spontaneously or were successfully treated, 149 (24.6%) presented with a subsequent HCV reinfection. Thirty out of 70 (43%) who cleared again or were successfully treated, presented with a second reinfection, 5 with a third, and one with a fourth reinfection. The reinfection incidence was 7.3/100 person-years (95% CI 6.2-8.6). We found a trend for lower incidence among individuals who had spontaneously cleared their incident infection than among individuals who were treated (Hazard ratio 0.62, 95% CI 0.38-1.02, p=0.06). Spontaneous clearance of reinfection was associated with ALT levels >1000IU/ml and spontaneous clearance of a prior infection.Conclusions HCV reinfection is an issue of major concern in HIV-positive MSM. Prevention strategies are needed for high risk groups to reduce morbidity and treatment costs. HIV-positive MSM with a prior HCV infection should be tested every 3 to 6months for reinfection. Those who had achieved a reinfection should be tested every 3months.Lay summary We evaluated the occurrence of HCV reinfection in HIV-positive men who have sex with men. We found an alarming incidence of 7.3/100 person-years. Prevention measures need to address this specific subgroup of patients at high risk for HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Because acute HCV infection acquisition among persons with HIV infection can occur, especially among MSM, and regular screening of those with HIV is cost-effective (238,239,1377), periodic HCV screening should be conducted (1378–1380).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1380]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, C. J., Ryom, L., Weber, R. K., Morlat, P., Pradier, C., Reiss, P., Kowalska, J. D., Wit, S. D., Law, M. G., El‐Sadr, W., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60604-8 · Cited by 950
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Muñoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 882
Pestka, J. M., Zeisel, M. B., Bläser, E., Schürmann, P., Bartosch, B., Cosset, F., Patel, A. H., Meisel, H., Baumert, J. J., Viazov, S. O., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607026104 · Cited by 565
Martin, N. K., Vickerman, P. T., Grebely, J., Hellard, M. E., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J., et al. (2013) · Hepatology · doi:10.1002/hep.26431 · Cited by 488
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Naggie, S., Cooper, C., Saag, M. S., Workowski, K., Ruane, P. J., Towner, W. J., Marks, K., Luetkemeyer, A. F., Baden, R. P., Sax, P. E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501315 · Cited by 467
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
Wyles, D. L., Ruane, P. J., Sulkowski, M., Dieterich, D. T., Luetkemeyer, A. F., Morgan, T. R. M., Sherman, K. E., Dretler, R. H., Fishbein, D. A., Gathe, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503153 · Cited by 411
Danta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281053a0c · Cited by 410
Self-citationOsburn, W. O., Fisher, B. E., Dowd, K. A., Urban, G., Liu, L., Ray, S. C., Thomas, D. L., & Cox, A. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.017 · Cited by 360
Bourne, A. H., Reid, D., Hickson, F. C. I., Rueda, S. T., & Weatherburn, P. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052052 · Cited by 330
Tillmann, H. L., Thompson, A. J. V., Patel, K., Wiese, M., Tenckhoff, H., Nischalke, H. D., Lokhnygina, Y. V., Kullig, U., Göbel, U., Capka, E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.005 · Cited by 321
Aspinall, E., Corson, S., Doyle, J., Grebely, J., Hutchinson, S. J., Dore, G. J., Goldberg, D. J., & Hellard, M. E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit306 · Cited by 310
Simmons, B., Saleem, J., Hill, A. M., Riley, R. D., & Cooke, G. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ948 · Cited by 308
Rockstroh, J. K., Nelson, M. R., Katlama, C., Lalezari, J. P., Mallolas, J., Bloch, M., Matthews, G. V., Saag, M. S., Zamor, P. J., Orkin, C. M., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00114-9 · Cited by 304
Self-citationDaskalopoulou, M., Rodger, A. J., Phillips, A. N., Sherr, L., Speakman, A., Collins, S., Elford, J., Johnson, M. A., Gilson, R. J. C., Fisher, M., et al. (2014) · The Lancet HIV · doi:10.1016/s2352-3018(14)70001-3 · Cited by 303
Self-citationSulkowski, M., Eron, J. J., Wyles, D. L., Trinh, R. N., Lalezari, J. P., Wang, C., Slim, J., Bhatti, L., Gathe, J., Ruane, P. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.1328 · Cited by 301
Page, K. A., Hahn, J. A., Evans, J. L., Shiboski, S. C., Lum, P. J., Delwart, E., Tobler, L. H., Andrews, W. J., Avanesyan, L., Cooper, S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605947 · Cited by 285
Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic.
Urbanus, A. T., van de Laar, T. J., Stolte, I. G., Schinkel, J., Heijman, T., Coutinho, R. A., & Prins, M. (2009) · AIDS · doi:10.1097/qad.0b013e32832e5631 · Cited by 276
van de Laar, T. J. W., Matthews, G. V., Prins, M., & Danta, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833c11a5 · Cited by 252
Grebely, J., Prins, M., Hellard, M. E., Cox, A. L., Osburn, W. O., Lauer, G. M., Page, K. A., Lloyd, A. R., & Dore, G. J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70010-5 · Cited by 229
Wiesch, J. S. Z., Ciuffreda, D., Lewis‐Ximenez, L. L., Kasprowicz, V. O., Nolan, B. E., Streeck, H., Aneja, J., Reyor, L. L., Allen, T. M., Lohse, A. W., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20100388 · Cited by 229
Ioannou, G. N., Bryson, C. L., Weiss, N. S., Miller, R., Scott, J. D., & Boyko, E. J. (2012) · Hepatology · doi:10.1002/hep.25800 · Cited by 205
Cross-Genotype Immunity to Hepatitis C Virus
Lanford, R. E., Guerra, B., Chavez, D., Bigger, C. B., Brasky, K. M., Wang, X., Ray, S. C., & Thomas, D. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1575-1581.2004 · Cited by 178
Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM
Martin, T., Martin, N. K., Hickman, M., Vickerman, P. T., Page, E. E., Everett, R., Gazzard, B., & Nelson, M. R. (2013) · AIDS · doi:10.1097/qad.0b013e32836381cc · Cited by 169
Self-citationLambers, F. A. E., Prins, M., Thomas, X., Molenkamp, R., Kwa, D., Brinkman, K., van der Meer, J. T. M., & Schinkel, J. (2011) · AIDS · doi:10.1097/qad.0b013e32834bac44 · Cited by 167
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
Thomson, E. C., Fleming, V. M., Main, J., Klenerman, P., Weber, J. N., Eliahoo, J., Smith, J., McClure, M. O., & Karayiannis, P. (2010) · Gut · doi:10.1136/gut.2010.217166 · Cited by 160
Kim, A. Y., Kuntzen, T., Timm, J., Nolan, B. E., Baca, M. A., Reyor, L. L., Berical, A. C., Feller, A. J., Johnson, K. L., Wiesch, J. S. Z., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.042 · Cited by 140
Martin, N. K., Thornton, A., Hickman, M., Sabin, C. A., Nelson, M. R., Cooke, G., Martin, T., Delpech, V., Ruf, M., Price, H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw075 · Cited by 133
Self-citationHepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs
Grady, B. P. X., Schinkel, J., Thomas, X. V., & Dalgård, O. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit301 · Cited by 97
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC 3 Study
Sacks‐Davis, R., Grebely, J., Dore, G. J., Osburn, W. O., Cox, A. L., Rice, T., Spelman, T., Bruneau, J., Prins, M., Kim, A. Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv220 · Cited by 94
Rosenthal, É., Roussillon, C., Salmon, D., Georget, A., Hénard, S., Huleux, T., Gueit, I., Mortier, E., Costagliola, D. G., Morlat, P., et al. (2014) · HIV Medicine · doi:10.1111/hiv.12204 · Cited by 80
Vickerman, P. T., Grebely, J., Dore, G. J., Sacks‐Davis, R., Page, K. A., Thomas, D. L., Osburn, W. O., Cox, A. L., Aitken, C. K., Hickman, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis213 · Cited by 67
Urbanus, A. T., van de Laar, T. J. W., Geskus, R. B., Vanhommerig, J. W., van Rooijen, M. S., Schinkel, J., Heijman, T., Coutinho, R. A., & Prins, M. (2013) · AIDS · doi:10.1097/qad.0000000000000126 · Cited by 67
Kokordelis, P., Krämer, B., Körner, C., Boesecke, C., Voigt, E., Ingiliz, P., Glässner, A., Eisenhardt, M., Wolter, F., Kaczmarek, D. J., et al. (2014) · Hepatology · doi:10.1002/hep.26782 · Cited by 59
Self-citationAbdelrahman, T., Hughes, J., Main, J., McLauchlan, J., Thursz, M. R., & Thomson, E. C. (2014) · Hepatology · doi:10.1002/hep.27192 · Cited by 42
Ingiliz, P., Krznaric, I., Stellbrink, H., Knecht, G., Lutz, T., Noah, C., Stocker, H., Obermeier, M., Dupke, S., Boesecke, C., et al. (2014) · HIV Medicine · doi:10.1111/hiv.12127 · Cited by 40
Self-citationBoesecke, C., Grint, D. J., Soriano, V., Lundgren, J. D., Monforte, A. D., Мицура, В. М., Chentsova, N. P., Hadžiosmanović, V., Kirk, O., Mocroft, A., et al. (2015) · Liver International · doi:10.1111/liv.12848 · Cited by 35
Self-citationTreatment of acute hepatitis C infection in HIV-infected patients
Boesecke, C., & Rockstroh, J. K. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834732cd · Cited by 23
Self-citationWandeler, G., Schlauri, M., Jaquier, M.-E., Rohrbach, J., Metzner, K. J., Fehr, J. S., Ambrosioni, J., Cavassini, M. L., Stöckle, M., Schmid, P., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv026 · Cited by 20
The NEAT study group, Boesecke, C., Ingiliz, P., Reiberger, T., Stellbrink, H., Bhagani, S. R., Page, E. E., Mauss, S., Lutz, T., Voigt, E., et al. (2015) · Infection · doi:10.1007/s15010-015-0856-9 · Cited by 12
Self-citation
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Bhattacharya, D., Aronsohn, A. I., Price, J. C., Re, V. L., Heald, J., Demisashi, G., Durzy, E., Davis-Owino, A., & Tynes, S. A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad319 · Cited by 345
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Safreed‐Harmon, K., Thursz, M. R., Dillon, J. F., El-Sayed, M. H., Elsharkawy, A. M., Hatzakis, A. E., Jadoul, M. Y., Prestileo, T., Razavi, H. A., Rockstroh, J. K., et al. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1666841 · Cited by 262
Self-citationBreakthroughs in hepatitis C research: from discovery to cure
Manns, M. P., & Maasoumy, B. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00608-8 · Cited by 242
Martinello, M., Solomon, S. S., Terrault, N. A., & Dore, G. J. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01320-x · Cited by 204
Metadata
- Authors
- Ingiliz, P., Martin, T. C., Rodger, A., Stellbrink, H.-J., Mauss, S., Boesecke, C., Mandorfer, M., Bottero, J., Baumgarten, A., Bhagani, S., Lacombe, K., Nelson, M., & Rockstroh, J. K.
- Affiliations
- Chelsea and Westminster Hospital (GB)
- The Royal Free Hospital (GB)
- Infektionsmedizinisches Centrum Hamburg (DE)
- Center for HIV and Hepatogastroenterology (DE)
- University of Bonn (DE)
- Medical University of Vienna (AT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Corresponding author
- Ingiliz, Patrick
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 66
- Issue
- 2
- Pages
- 282-287
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2520350813
- Cited by
- 173
- References
- 39
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 19 · 2021: 14 · 2020: 19 · 2019: 35 · 2018: 30 · 2017: 18
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Funders
- NEAT (LSHP-CT-2006-037570)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- HIV/HCV coinfection, men who have sex with men, spontaneous HCV clearance, ALT levels
- MeSH terms
- Adult, Antiviral Agents, Communicable Disease Control, Europe, Female, Hepatitis C, HIV Seropositivity, Humans, Male, Middle Aged, HIV Infections, Incidence, Hepacivirus, Homosexuality, Male, Coinfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
